|
Figure 4.
Fig. 4. Schematic representation of the functional
mechanism of FMO. Only the relevant parts required to explain
the function, isoalloxazine, nicotinamide, and methimazole, are
shown. Step 1 is seen in the wild type, step 3 is seen in the
protein–cofactor complex, and step 5 is seen in the
protein–methimazole complex structures.
|